Pep Lib

Answer: PepLib's official website is https://peplib.com

Answer: PepLib's revenue is Under $1 Million

Answer: PepLib has 51-200 employees

Answer: PepLib is in Biotechnology

Answer: PepLib contact info: Phone number: Website: https://peplib.com

Answer: Zonsen PepLib Biotech Inc. is a high-tech biopharmaceutical enterprise that is dedicated to advancing global innovation in the discovery of new peptide drugs. Founded in September 2017, PepLib is headquartered in Zhuzhou, China, with a subsidiary in New Jersey, USA. Our core peptide discovery platform is called Peptide Information Compression Technology (PICT), which consists of a diverse peptide library named ZSenithFive, containing information on nearly half-billion peptides. The PICT platform is ideal for the discovery of functionally active peptides directly from cell-based and biochemical high-throughput screening (HTS) assays. In addition, we have developed 4 complimentary peptide discovery platforms: the Disulfide-rich Peptide Phage Display (DRP-PD) platform, the Animal Toxin Peptide Library Platform, the Nano-Cyclic Peptide Library Platform, and the Virtual Peptide Library Platform. PepLib successfully raised 100 million yuan (USD 16 million) in Series Pre-A financing in 2019 and secured Series A financing of 220 million yuan (USD 35 million) in 2021. PepLib has been working towards Series Pre-IPO financing since March 2022. PepLib has more than 190 employees, and more than 80% of the workforce is made up of R&D personnel. At PepLib, our main therapeutic area focus is oncology and cardiometabolic diseases. where oncology programs are driven by the development of peptide drug conjugates (PDCs) and peptide radionuclide conjugates (PRCs).

Answer:

• LinkedIn